Pharmacological activation of the ryanodine receptor in Jurkat T-lymphocytes

British Journal of Pharmacology

Volumn 128, Issue 6, 1999, Pages 1235-1240

  Hohenegger, Martin ^a   Berg, Ingeborg ^b   Weigl, Lukas ^a   Mayr, Georg W ^b   Potter, Barry V L ^c   Guse, Andreas H ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF HAMBURG   (Germany)

^c University of Bath   (United Kingdom)

Author keywords

Cyclic ADP ribose; Inositol triphosphate; Jurkat T lymphocytes; Ryanodine receptor; Suramin; T cell activation

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ANTITRYPANOSOMAL AGENT; CALCIUM ION; FURA 2; INOSITOL 1,4,5 TRISPHOSPHATE; RUTHENIUM RED; RYANODINE RECEPTOR; SURAMIN; T LYMPHOCYTE RECEPTOR;

ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CELL MEMBRANE; DOSE RESPONSE; HEART MUSCLE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MICROINJECTION; PIPETTE; PRIORITY JOURNAL; SKELETAL MUSCLE; T LYMPHOCYTE;

EID: 0032714428     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702935     Document Type: Article

References (31)

1. ALBEROLA, I.J., TAKAKI, S., KERNER, J.D. & PERLMUTTER, R.M. (1997). Differential signalling by lymphocyte antigen receptors. Annu. Rev. Immunol., 15, 125-154.
2. 2+ release. Biochemistry, 36, 9509-9517.
3. BERRIDGE, M.J. (1997). Lymphocyte activation in health and disease. Crit. Rev. Immunol., 17, 155-178.
4. CLAPHAM, D.E. (1995). Calcium Signalling. Cell, 80, 259-268.
5. CRABTREE, G.R. & CLIPSTONE, N.A. (1994). Signaltransmission between the plasma membrane and the nucleus of T lymphocytes. Ann. Rev. Biochem., 63, 1045-1083.
6. EMMICK, J.T., KWON, S., BIDASEE, K.R., MESCH, K.T. & BESCH, H.R. (1994). Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes. J. Pharmacol. Exp. Ther., 269, 717-724.
7. FRUEN, B.R, MICKELSON, J.R., SHOMER, N.H., VELEZ, P. & LOUIS, C.F. (1994). Cyclic ADP-ribose does not affect cardiac or skeletal muscle ryanodine receptors. FEBS Lett., 352, 123-126.
8. 2+ Channel that is regulated by TGF-β. Science, 257, 91-94.
9. GIANNINI, G., CONTI, A., MAMMARELLA, S., SCROBOGNA, M. & SORRENTINO, V. (1995). The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J. Cell Biol., 128, 893-904.
10. 2+ signalling in the T-lymphocytes. Crit. Rev. Immunol., 18, 419-448.
11. 2+ mobilising second messenger. Cell Signal., 11, 309-316.
12. 2+ entry induced via cyclic ADP-ribose in intact T-lymphocytes. J. Biol. Chem., 272, 8546-8550.
13. 2+-signalling in T-lymphocytes by the second messenger cyclic ADP-ribose. Nature, 398, 70-73.
14. 2+ -release in T lymphocyte cell lines. J. Immunol., 155, 3353-3359.
15. 2+ pools in Jurkat T-lymphocytes. Biochem. J. 291, 447-451.
16. HAGAR, R.E., BURGSTAHLER, A.D., NATHANSON, M.H., & EHRLICH, B.E. (1998). TypeIII InsP3 receptor channel stays open in the presence of increased calcium. Nature, 396, 81-84.
17. HAKAMATA, Y., NAKAI, J., TAKESHIMA, H., & IMOTO, K. (1992). Primary structure and distribution of a novel ryanodine receptor/ calcium release channel from rabbit brain. FEBS Lett., 312, 229-235.
18. HAKAMATA, Y., NISHIMURA, S., NAKAI, Y. J., NAKSHIMA, Y., KITA, T. & IMOTO, K. (1994). Involvement of the brain type ryanodine receptor in T-cell proliferation. FEBS Lett., 352, 206-210.
19. HOHENEGGER, M., MATHYASH, M., POUSSU, K., HERRMANN-FRANK, A., SARKÖZI, S., LEHMANN-HORN, F. & FREISSMUTH, M. (1996). Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogs. Mol. Pharmacol., 50, 1443-1453.
20. JAYARAMAN, T., ONDRIASOVE, E., ONDRIAS, K., HARNICK, D.J. & MARKS, A.R. (1995). The inositol 1,4,5-triphosphate receptor is essential for T-cell receptor signalling. Proc. Natl. Acad. Sci. U.S.A., 92, 6007-6011.
21. KLINGER, M., FREISSMUTH, M., NICKEL, P., STÄBLER-SCHWARZBART, M., KASSACK, M., SUKO, J. & HOHENEGGER, M. (1999). Suramin and suramin analogs activate skeletal muscle ryanodine receptor via a calmodulin binding site. Mol. Pharmacol., 55, 462-472.
22. LEEB, T. & BRENIG, B. (1998). cDNA cloning and sequencing of the human ryanodine receptor type 3 (RyR3) reveals a novel alternative splice site in the RyR3 gene. FEBS Lett., 423, 367-370.
23. MARKS, A.R. (1997). Intracellular calcium-release channels: regulators of cell life and death. Am. J. Physiol., 272, H597-H605.
24. 2+ release channels and their regulation by endogenous effectors. Annu. Rev. Physiol., 56, 485-508.
25. MILLS, S.J. & POTTER, B.V.L. (1996). Synthesis of D-and L-myo-inositol 1,4,6-trisphosphate, regioisomers of a ubiquitous second messenger. J. Org. Chem., 61, 8980-8987.
26. 2+ -mobilising partial agonists at the inositol 1,4,5-trisphosphate receptor. Bioorg. Med. Chem. Lett., 5, 203-208.
27. MURAYAMA, Y. & OGAWA, Y. (1996). Properties of ryr3 ryanodine receptor isoform in mammalien brain. J. Biol. Chem., 271, 5079-5084.
28. NAKASHIMA, Y., NISHIMURA, S., MAEDA, A., BARSOUMIAN, E.L., HAKAMATA, Y., NAKAI, J., ALLEN, P.D., IMOTO, K. & KITA, T. (1997). Molecular cloning and characterisation of a human brain ryanodine receptor. FEBS Lett., 417, 157-162.
29. SUGIYAMA, T., FURUYA, A., MONKAWA, T., YAMAMOTO-HINO, M., SATOH, S., OHMORI, K., MIYAWAKI, A., HANAI, N., MIKOSHIBA, K. & HASEGAWA, M. (1994). Monoclonal antibodies distinctively recognizing the subtypes of inositol 1,4,5-trisphosphate receptor: application to the studies on inflammatory cells. FEBS-Lett., 354, 149-154.
30. WARD, S.G. & WESTWICK, J. (1998). Chemokines: understanding their role in T-lymphocyte biology. Biochem. J., 333, 457-470.
31. 2+ channel/ ryanodine receptor: Modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev., 49, 1-48.